AstraZeneca in $1.15B Deal for Pearl Therapeutics

June 10 (Bloomberg) -- Bloomberg's Anna Edwards reports that AstraZeneca has agreed to a $1.15 billion deal to buy Pearl Therapeutics, a maker of therapies for respiratory disease. She speaks on Bloomberg Television's "Countdown."
Singapore's New Normal: ANZ Makes Case for Low Growth
56:07 - Weiwen Ng, an economist at Australia & New Zealand Banking Group Ltd., talks about Singapore's economy and central bank policy after the nation narrowly avoided a technical recession. Ng speaks with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)
  • Weaker Yuan: Why RBC's Tenengauzer Sees Declines in 2016
  • The Top Three Stocks to Watch in Asia Today
  • JPMorgan Earnings: What'd You Miss? (Full Show 10/13)